Mao, Chao http://orcid.org/0000-0002-8685-8539
Liu, Xiaoguang http://orcid.org/0000-0001-6977-5128
Zhang, Yilei http://orcid.org/0000-0003-1407-0301
Lei, Guang http://orcid.org/0000-0002-3282-0666
Yan, Yuelong http://orcid.org/0000-0001-8495-6445
Lee, Hyemin
Koppula, Pranavi http://orcid.org/0000-0002-7567-1891
Wu, Shiqi
Zhuang, Li
Fang, Bingliang
Poyurovsky, Masha V.
Olszewski, Kellen http://orcid.org/0000-0001-9691-0831
Gan, Boyi http://orcid.org/0000-0001-8884-6040
Article History
Received: 25 June 2020
Accepted: 7 April 2021
First Online: 12 May 2021
Change Date: 2 August 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41586-021-03820-9
Competing interests
: K.O. and M.V.P. are full-time employees of Kadmon Corporation, LLC. B.G., K.O., and M.C. have filed a patent application relating to the use of DHODH inhibitors to target ferroptosis in cancer therapy. Other authors declare no competing financial interests.